The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...
Rebecca Douglas is a strategic leader with a passion for nurturing talent. With an award-winning track record in developing ...
Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...
Almost half of UK doctors would not use generative artificial intelligence (GenAI) to treat patients, although there is greater willingness to use it for diagnostic purposes. A survey of 745 ...
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...
AI has the potential to transform pharmaceutical supply chains by enhancing visibility and predicting disruptions. Traditional supply chains often suffer from a lack of transparency, making it ...
Up until recently, political rhetoric targeting the pharma industry had been largely all bark and no bite. Ben Hargreaves finds that the Biden-Harris Administration has finally shown its teeth and ...
Patients in England and Wales with a rare genetic disorder will soon be able to access treatment with MSD's Welireg via the NHS, nearly a year after their counterparts in Scotland. In final draft ...
As of 2024, more than one-third of American adults don't get enough sleep, and sleep satisfaction levels are worryingly low. Sleep is connected to our daily functioning, broader health, and safety.
Welcome to the August edition of Changing Faces for the pharma and biotech sectors. We’ve gone beyond the press releases for this one with a few hires picked up on different channels which you ...
A virtual voice assistant that calls patients after heart procedures can allow them to be discharged from hospital earlier and identify patients who may need follow-up interventions, according to ...